How to read the manufacturer's six regenerative endpoints
Quick answer
The EUPOTON deck shows six lab endpoints: growth-factor profile, cell proliferation, wound healing/migration, angiogenesis, vascular tissue formation and regenerative-factor release — for example, cell count rising from 100 to 210 cells/mm² at 100% concentration. All are in-vitro results, not patient outcomes.
Proliferation: media 100 cells/mm², 30% = 150, 50% = 180, 100% = 210 — a dose-dependent trend in the experiment.
Angiogenesis: fluorescence 10 for control, 70 for bFGF, 90 for the test group. Factor release: FECS Aid showed IL-6 around 180,000 and IL-8 around 170,000 versus 50,000 in the 2D group.
Read carefully: dish results suggest possible mechanisms, but the human body is far more complex. Good lab data does not guarantee treatment results; ask for peer-reviewed patient studies.
Note: this article summarises the manufacturer's materials. Lab figures are in-vitro results, not human treatment outcomes, and nothing here is medical advice. Clinical use follows local approvals and physician judgment. For the overview, see What is EUPOTON.
No, they are laboratory results.
The effect increased with the concentration used.
Growth factors, proliferation, wound healing, angiogenesis, vascular tissue, regenerative-factor release.
Published patient studies, participant numbers and reported side effects.
The manufacturer presents it as activating a regenerative environment from the patient's own blood. Its materials do not show proof of curing any specific disease in humans, so ask a physician for clinical evidence first.
5 points • reviewed 2026-11-08
Reviewed and last updated: 2026-11-08
4 sources • every claim is traceable
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-11-08 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories